IgG4-related sclerosing cholangitis.
作者信息
Culver Emma L, Barnes Eleanor
机构信息
Translational Gastroenterology Department John Radcliffe Hospital Oxford United Kingdom.
Peter Medawar Building, Nuffield Department of Medicine University of Oxford Oxford United Kingdom.
出版信息
Clin Liver Dis (Hoboken). 2017 Jul 28;10(1):9-16. doi: 10.1002/cld.642. eCollection 2017 Jul.
Abstract
摘要
相似文献
1
IgG4-related sclerosing cholangitis.
Clin Liver Dis (Hoboken). 2017 Jul 28;10(1):9-16. doi: 10.1002/cld.642. eCollection 2017 Jul.
2
Isolated IgG4-related sclerosing cholangitis misdiagnosed as malignancy in an area with endemic cholangiocarcinoma: a case report.
BMC Surg. 2017 Feb 15;17(1):17. doi: 10.1186/s12893-017-0214-1.
3
IgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma.
Scand J Gastroenterol. 2015 Apr;50(4):447-53. doi: 10.3109/00365521.2014.962603. Epub 2015 Jan 30.
4
Immunoglobulin G4-related cholangitis: a variant of IgG4-related systemic disease.
Dig Dis. 2012;30(2):216-9. doi: 10.1159/000336706. Epub 2012 Jun 20.
5
Pathology and immunopathology of immunoglobulin G4-related sclerosing cholangitis: The latest addition to the sclerosing cholangitis family.
Hepatol Res. 2007 Oct;37 Suppl 3:S478-86. doi: 10.1111/j.1872-034X.2007.00243.x.
6
IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis.
Gut Liver. 2019 May 15;13(3):300-307. doi: 10.5009/gnl18085.
7
IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy.
Pancreatology. 2006;6(1-2):132-7. doi: 10.1159/000090033. Epub 2005 Dec 1.
8
Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and IgG4-related sclerosing cholangitis.
J Gastroenterol Hepatol. 2015 Jun;30(6):1104-9. doi: 10.1111/jgh.12894.
9
IgG4 Sclerosing Cholangitis - an Inflammation Imitating Tumour of the Pancreas and Biliary Tract.
Klin Onkol. 2019 Spring;32(2):143-151. doi: 10.14735/amko2019143.
10
Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
J Gastroenterol. 2017 Apr;52(4):483-493. doi: 10.1007/s00535-016-1246-5. Epub 2016 Jul 28.
引用本文的文献
1
Successful Use of a Novel High-Dose Mycophenolate Mofetil and Rituximab Regimen for Progressive IgG4 Sclerosing Cholangitis With Multisystemic Involvement.
ACG Case Rep J. 2025 Apr 16;12(4):e01672. doi: 10.14309/crj.0000000000001672. eCollection 2025 Apr.
2
A Review on Biomarkers for the Evaluation of Autoimmune Cholestatic Liver Diseases and Their Overlap Syndromes.
Front Mol Med. 2022 Jul 8;2:914505. doi: 10.3389/fmmed.2022.914505. eCollection 2022.
3
Isolated IgG4 Autoimmune Cholangitis in the Absence of Pancreatitis.
Cureus. 2022 Mar 1;14(3):e22754. doi: 10.7759/cureus.22754. eCollection 2022 Mar.
4
Hepatobiliary manifestations in inflammatory bowel disease: A practical approach.
World J Hepatol. 2022 Feb 27;14(2):319-337. doi: 10.4254/wjh.v14.i2.319.
5
Immunoglobulin G4 Cholangiopathy Masquerading as a Klatskin Tumor: An Interesting Case.
Cureus. 2021 Aug 31;13(8):e17624. doi: 10.7759/cureus.17624. eCollection 2021 Aug.
6
Review of primary sclerosing cholangitis with increased IgG4 levels.
World J Gastroenterol. 2020 Jun 21;26(23):3126-3144. doi: 10.3748/wjg.v26.i23.3126.
7
Differentiating IgG4-related sclerosing cholangiopathy from cholangiocarcinoma using CT and MRI: experience from a tertiary referring center.
Abdom Radiol (NY). 2019 Jun;44(6):2111-2115. doi: 10.1007/s00261-019-01944-1.
8
Cholangiopathies - Towards a molecular understanding.
EBioMedicine. 2018 Sep;35:381-393. doi: 10.1016/j.ebiom.2018.08.024. Epub 2018 Sep 17.
本文引用的文献
1
IgG4-related disease-experience of 100 consecutive cases from a specialist centre.
Histopathology. 2017 Apr;70(5):798-813. doi: 10.1111/his.13136. Epub 2017 Jan 24.
2
IgG4-related hepatobiliary disease: an overview.
Nat Rev Gastroenterol Hepatol. 2016 Oct;13(10):601-12. doi: 10.1038/nrgastro.2016.132. Epub 2016 Sep 14.
3
Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK Cohort.
Am J Gastroenterol. 2016 May;111(5):733-43. doi: 10.1038/ajg.2016.40. Epub 2016 Apr 19.
4
Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011.
Pancreas. 2015 May;44(4):535-9. doi: 10.1097/MPA.0000000000000325.
5
International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease.
Arthritis Rheumatol. 2015 Jul;67(7):1688-99. doi: 10.1002/art.39132.
6
Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort.
Am J Gastroenterol. 2014 Oct;109(10):1675-1683. doi: 10.1038/ajg.2014.223. Epub 2014 Aug 26.
7
Exposure to occupational antigens might predispose to IgG4-related disease.
Hepatology. 2014 Oct;60(4):1453-4. doi: 10.1002/hep.26999. Epub 2014 Aug 25.
8
Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis.
Hepatology. 2014 May;59(5):1954-63. doi: 10.1002/hep.26977. Epub 2014 Apr 1.
9
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis.
Gut. 2013 Dec;62(12):1771-6. doi: 10.1136/gutjnl-2012-303617. Epub 2012 Dec 11.
10
Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience.
Gut. 2013 Nov;62(11):1607-15. doi: 10.1136/gutjnl-2012-302886. Epub 2012 Aug 30.
Zotero 插件